Search results
Results from the WOW.Com Content Network
The Boston Diagnostic Aphasia Examination provides a comprehensive exploration of a range of communicative abilities. Its results are used to classify patient's language profiles into one of the localization based classifications of aphasia: Broca's, Wernicke's, anomic, conduction, transcortical, transcortical motor, transcortical sensory, and global aphasia syndromes, although the test does ...
The Boston Naming Test (BNT), introduced in 1983 by Edith Kaplan, Harold Goodglass and Sandra Weintraub, is a widely used neuropsychological assessment tool to measure confrontational word retrieval in individuals with aphasia or other language disturbance caused by stroke, Alzheimer's disease, or other dementing disorder. [1]
This page was last edited on 13 September 2024, at 16:43 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The Boston Diagnostic Aphasia Examination (BDAE) and the Western Aphasia Battery (WAB) are two commonly used test batteries for diagnosing conduction aphasia. These examinations involve a set of tests, which include asking person to name pictures, read printed words, count aloud, and repeat words and non-words (such as shwazel). Neuro-imaging ...
The WAB–R is a battery of 8 subtests (32 short tasks). It maintains the structure, content, and clinical value of the earlier test. Additions: [1] Two supplementary tasks (reading and writing irregular verbs and non-words) to aid the clinician in distinguishing surface, deep (phonological), and visual dyslexia.
There are 5 receptive subtests (3 auditory comprehension, 2 visual comprehension) and 16 expressive subtest (5 repetition, 3 naming, 4 reading, 4 writing) Neuropsychological deficits that could be associated with aphasia are tested in 6 subtests (line bisection, semantic memory, word fluency, recognition memory, gesture object use, arithmetic).
The Halstead–Reitan Neuropsychological Test Battery (HRNB) and allied procedures is a comprehensive suite of neuropsychological tests used to assess the condition and functioning of the brain, including etiology, type (diffuse vs. specific), localization and lateralization of brain injury.
The Differential Ability Scales (DAS) is a nationally normed (in the US), and individually administered battery of cognitive and achievement tests. Into its second edition (DAS-II), the test can be administered to children ages 2 years 6 months to 17 years 11 months across a range of developmental levels.